Clinical Trial Update: Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia [Phase 3]

View source ↗

Summary

Phase 3 trial investigating caffeine versus probiotic for preterm neonates with bronchopulmonary dysplasia; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Caffeine (caffeine)
• Probiotic (probiotic)

Snippet

Sponsor: Tanta University | Conditions: Bronchopulmonary Dysplasia | Phase 3 | Status: UNKNOWN